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ABSTRACT
Objective: To determine the accuracy of Ziehl-Neelsen microscopy in the diagnosis of 
TB in setings of high HIV prevalence.  
Design: Cross-sectional descriptive study. 
Setting: Hospitals serving areas of high human immunodeficiency virus prevalence 
in western Kenya. The study was conducted between September 2007 and September 
2009.
Results: In total, 341/872 (39.1%) of the TB suspects were positive in ZN, 53.1% (181/341) 
of them culture positive. Only 3.8% (20/531) of the ZN smear negatives were culture 
positive.  Of the 695 suspects evaluated for both Mycobacterium and HIV infection, 
255 (36.7%) were ZN smear positive, 42.7% of them HIV positive.  Out of the 440 ZN 
smear negatives, 37% were HIV positive.  Similarly, 168 suspects were culture positive, 
46.4% of them HIV positive.  The HIV infection did not significantly reduce ZN smear 
positivity rate (P = 0.42) and culture sensitivity (P = 0.09). The ZN sensitivity and 
specificity were 88.1% and 79.7%, respectively. The predictive values were 58.0 (PPV), 
and 95.5% (NPV), respectively. However, the area under the ROC curve was 0.84, with 
95% CI between 0.80-0.87 and P< 0.001). The ZN smear microscopy had a lesser ability 
to distinguish between TB and non-TB cases compared to culture.  
Conclusion: ZN microscopy causes a significant over-diagnosis of TB in settings of 
high HIV/AIDS prevalence. There is need for further studies on this subject taking 
into consideration the various confounding factors.
INTRODUCTION
Human  immunodeficiency virus (HIV) and 
tuberculosis (TB) co-infection interact patho-
physiologically, clinically and epidemiologically (1). 
Many differences between TB and TB-HIV patients 
have been described, yielding important diagnostic 
implications. In immuno-competent patients, 
pulmonary TB accounts for about 80% of the cases 
(2). In early stage of HIV infection, the frequency 
and presentation of TB is similar to that observed in 
immuno-competent and HIV negative patients, while 
at a later stage of HIV infection it varies with the severity 
of immunosuppression (1,3).  As a consequence, while 
extra-pulmonary TB accounts for only 20% of the TB 
cases in HIV negative patients, it accounts for 53-62% 
of the HIV positive patients (4,5).  Tuberculosis is also 
more likely to be disseminated in HIV positive than in 
HIV negative cases and is more difficult to diagnose 
by conventional diagnostic procedures because of 
immunosuppression due to HIV/AIDS progression 
(1).
 The Ziehl-Neelsen (ZN) smear microscopy to 
detect Acid Fast Bacilli (AFB) in clinical specimens is 
still the corner-stone and the only cost-effective tool 
for diagnosing pulmonary TB and to monitor anti-TB 
chemotherapy in most resource-poor settings (6,7). 
This is not a favourable situation as culture is the 
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gold standard for diagnosis of TB and to determine 
treatment success (8). Moreover, the diagnosis of TB 
in HIV infected patients is difficult because of absence 
of conventional symptoms, negative sputum smears, 
atypical chest radiography, higher prevalence of extra-
pulmonary TB, and resemblance to other opportunistic 
pulmonary infections, posing a diagnostic challenge 
(9). The HIV infected smear positive patients tend to 
excrete significantly fewer TB bacilli in the sputum 
than HIV negative patients, which may lead to the 
AFBs being missed on microscopic examination. 
Therefore, HIV/AIDS infection has been associated 
with increased sputum smear negative TB cases which 
may be culture positive (10,11).  
 Tuberculin negative test (12) and smoking 
(13) have also been associated with lower smear 
microscopy and sputum culture positivity rates. 
However, although data on factors associated with 
an increased risk of smear negative in combination 
with culture positive results are still scarce (14), it is 
known that a substantial number of TB patients in 
high HIV prevalent and TB high-burden countries 
will be smear-negative (10,14).  The growing number 
of individuals with TB-HIV co-infection (50-60%) 
in Kenya (15,16) poses several challenges in early 
diagnosis, prevention, prophylaxis and treatment 
of TB (17). There is also the emergence of non-
tuberculous mycobacteria (NTM) as opportunistic 
pathogens among HIV/AIDS patients, and ZN smear 
microscopy does not differentiate between TB and 
NTM disease.  The current study was designed to 
determine the accuracy of ZN smear microscopy and 
demonstrate its tendency to diagnose NTM disease 
as TB in Western Kenya in the current era of high 
HIV prevalence.
MATERIALS AND METHODS
Study site and population:  The study was done at chest 
and paediatric clinics at one provincial, one level 5, 
and eight district hospitals in western Kenya.  These 
were Busia, Bungoma, Kisumu, Migori, Kisii (Level 
5), Narok, Kericho, Uasin Gishu and Lodwar district 
hospitals, and Nakuru Provincial General Hospital. 
Western Kenya includes the expansive former Rift 
Valley, Nyanza and Western Provinces, with a 
cumulative population of about 19.8 million people, 
constituting about 52.1% of the Kenyan population, 
according to the Kenya Census of 2009 (18).  Western 
Kenya region is served by many health facilities 
including health centres, sub-district hospitals, 
district hospitals and three provincial hospitals, 
and one teaching and referral hospital.  There was 
no data available on TB and HIV in the individual 
areas where the selected hospitals for the present 
study are located.  However, data available in 
the 2007-2009 annual reports of the Division of 
Leprosy, Tuberculosis and Lung Disease (DLTLD) 
(15,19,20) indicate up to 60% TB cases to be HIV 
co-infected.
Sampling frame and patient characteristics: Purposeful 
sampling was employed in recruiting TB suspects 
into the study as they sought healthcare at chest 
and paediatric clinics.  Suspects between 9 months 
and 80 years old were enrolled into the study. 
Patients were suspected of having TB if they had 
a cough of more than two weeks not responding 
to antibiotic treatment (21).
Inclusion and exclusion criteria:  Those suspected of 
having TB and resident in western Kenya for at 
least six months, not on anti-TB chemotherapy and 
consented to participate in the study were recruited. 
Suspects who had not lived in Western Kenya for the 
last 6 months, those already on anti-TB chemotherapy, 
and those unwilling to participate in the study and not 
meeting the above inclusion criteria were excluded. 
Children under 18 years were enrolled into the study 
after receiving consent from legal guardians.
Collection of demographic data: Counseling and 
collection of demographic data were done by 
clinicians / nurses running the chest and paediatric 
clinics. Interview questionnaire was used to obtain 
the demographic data.  The data collected included 
age, gender, previous anti-TB treatment, and HIV 
status.
Collection of sputum and blood samples: Three sputum 
specimens (spot, early morning, spot) were collected 
from 872 TB suspects under the supervision of 
trained and competent medical staff.  The patients 
were requested to cough so that expectoration would 
come from deep down the chest as possible, and spit 
into a sterile 50 ml blue cap tubes.  For children less 
than five years of age and those less than ten years 
of age unable to expectorate sputum had sputum 
induction performed at the Nakuru Provincial and 
Kisii level five hospitals.  The sputum induction 
involving six children was done by paediatricians 
using hypertonic (3%) saline (22). The samples were 
refrigerated at 4ºC awaiting transportation in cool 
boxes to the Mycobacteria Reference Laboratory, 
Moi University School of Medicine (MRL, MUSOM) 
weekly for analysis (ZN smear microscopy, culture, 
identification of isolates and drug susceptibility 
testing).  Samples were processed within seven days 
of collection in order to minimise loss of viability 
of the mycobacteria.  Consenting 695 participants 
also underwent phlebotomy for HIV testing.  The 
blood was delivered into Vacutainer Brand STERILE 
interior EDTA (K3) tubes and stored at –20oC awaiting 
processing.  The samples were transported in cool 
boxes to MRL, MUSOM, Eldoret, and processed 
within two weeks.  The safety for research assistants 
and healthcare workers during collection and 
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handling of sputum specimens was ensured by 
observing the WHO guidelines (23).
HIV testing:  Testing for HIV infection was done 
by screening serum with the Trinity Biotech Uni-
GoldTM test 24 and confirmed with the enzyme 
linked immunosorbent assay (25).
Microscopic examination of specimens:  Sputum smears 
were examined for acid-fast bacilli (AFB) after staining 
following ZN method (26).  The degree of ZN smear 
positivity was quantified as 1+ for 10 -100 AFBs per 
100 fields, 2+ for 1-10 AFBs per field (50 fields), and 
3+ for > 10 AFBs per field (20 fields).  For less than 10 
AFBs per 100 fields, the exact number of AFBs was 
indicated.  A suspect was considered to be ZN smear 
positive if at least one specimen was positive.
Isolation of mycobacteria and identification of mycobacteria: 
Sputum specimens were processed for isolation of 
mycobacteria following standard protocols (27).  A 
participant with at least one positive culture (MGIT 
and / or LJ) was considered as a TB case, while those 
with three negative culture results were regarded 
as not having TB.  The mycobacterial isolates were 
identified as M. tuberculosis complex or species of 
non-tuberculous mycobacteria (NTM) using Hain’s 
GenoType® Mycobacterium CM and GenoType® 
Mycobacterium AS Molecular Genetic Assays, 
following manufacturer’s instructions (28). The 
suspects with ZN smear positive but culture negative 
sputa were treated as smear negative pulmonary TB 
cases.
Quality control for ZN microscopy and culture: Standard 
Operating Procedures (SOPs) used at Mycobacteria 
Reference Laboratory of Moi University School of 
Medicine were followed for microscopy and culture. 
M. tuberculosis (H37Rv) was used as a positive 
control, and Escherichia coli as a negative control and 
all new batches of microscopy reagents. Similarly, M. 
tuberculosis (H37Rv) positive control and a negative 
E. coli were inoculated once a day together with the 
first batch of LJ slants and MGIT tubes for that day. 
An experienced microscopist read an arbitrary 10% 
positive and 10% negative slides randomly selected, 
with concordance of 99% and 97%, respectively.  The 
smears with discordant results were confirmed as 
positives or negatives using MGIT cultures.
Data analysis:  Data were entered in MS Excel 8.0 and 
analysed using Epi Info version 3.5.1.  Descriptive 
statistics were used to summarise data into 
proportions. Logistic regression was used to calculate 
odds ratio (OR), 95% confidence intervals (CI) and 
P-values to assess how HIV co-infection infection 
related to ZN smear microscopy and culture.  The 
sensitivity, specificity, predictive (NPV and PPV) 
values were computed. The k coefficient and ROC 
curve were calculated using ZN smear results as 
nominal data.
Ethical issues: The proposal for this study was 
approved by ITROMID / KEMRI’s Scientific Steering 
Committee (SSC) and Ethics Review Committee 
(ERC) [SSC No. 837] and by Moi University School 
of Medicine (MU-SOM) / Moi Teaching and Referral 
Hospital (MTRH) Institutional Research and Ethics 
Committee (IREC) [FAN No.00092]. The study was 
conducted in accordance with the Declaration of 
Helsinki 29. Results on TB, NTM disease and HIV 
infection were availed to respective healthcare givers 
for appropriate patient care. The HIV positive cases 
were referred for post-test counselling and enrolment 
to HIV/AIDS Programme.
RESULTS
A total of 872 eligible TB suspects were enrolled into 
the study and screened for TB.  However, 177 suspects 
declined HIV test without explanation.
ZN smear microscopy and culture:  Specimens from 
39.1% (341/872) participants were ZN smear positive, 
of which 53.1% (181/341) were culture positive 
and 46.9% (160/341) were culture negative.  The 
distribution of culture negative sputa among the 
various degrees of ZN smear positive samples were 
13.1% (21/160) for 3+, 23.1% (37/160) for 2+, 30.6% 
for 1+ and 33.1% (53/160) the sputa with less than 
10 AFBs per 100 fields. There was no correlation 
between ZN smear positivity and culture negativity. 
Only 3.8% (20/531) of the ZN smear negative were 
culture positive. Hence, 41.4% (361/872) suspects 
were infected with mycobacteria, of which 44.3% 
(160/361) were culture negative and 55.7% (201/361) 
were culture positive.  Of the culture positives, 92.5% 
were M. tuberculosis complex and 7.5% were NTM. 
The five isolates from the NTM infection cases were 
identified as M. intracellulare (three isolates), and 
one each as M. fortuitum and M. peregrinum.  The 
remaining ten NTM isolates could not be identified to 
species level.  The 46.9% (160/341) ZN smear positive, 
culture negative cases were also treated as TB cases. 
None of the cultures yielded combined tuberculous 
and non-tuberculous mycobacteria co-infection. 
Smear microscopy, culture and HIV infection:  Among 
the 695 TB suspects tested for HIV infection, 255 
were ZN smear positive (109 of the HIV infected) 
and 168 suspects were culture positive (78 of them 
HIV infected) (Table 1).
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Table 1
ZN microscopy, TB culture and HIV infection
 ZN smear microscopy       TB culture 
N = 695  ZN smear  ZN smear  Culture Culture
 positive negative positive negative
HIV positive 109 163 78 194
HIV negative 146 277 90 333
Totals 255 440 168 527
Socio-demographic variables among TB and TB-HIV 
patients: Among the 695 TB suspects tested for HIV 
infection, 152 suspects (103 males and 49 females) had 
TB alone and 112 suspects (63 males and 49 females) 
were co-infected with HIV. Majority of the TB and 
TB-HIV cases were in the 15-44 age bracket, with 
males more affected (Table 2).
Table 2 
Socio-demographic variables among TB and TB-HIV patients
Age-group TB patients (N = 152) TB-HIV patients (N = 112) 
 Males Females Males Females
0-14 3(2.9) 2(4.1) 2(3.2) 2(4.1)
15-24 20(19.4) 11(22.4) 13(20.6) 8(16.3)
25-34 37(35.9) 22(44.9) 26(41.3) 21(42.9)
35-44 24(23.3) 6(12.2) 15(23.8) 13(26.5)
45-54 11(10.7) 5(10.2) 4(6.3) 3(6.1)
55-64 4(3.9) 2(4.1) 2(3.2) 1(2.0)
> 64 4(3.9) 1(2.0) 1(1.6) 1(2.0)
Total 103 (100) 49 (100) 63(100) 49(100)
ZN smear and culture results among TB and TB-HIV 
patients: A total of 264 (166 males and 98 females) 
were among the TB cases who accepted HIV test, and 
42.4% (112/264) were co-infected. Males constituted 
56 % (63/112) and females 44% (49/112) of TB-HIV 
cases.  Among the 152 non-HIV TB cases, 140 were ZN 
smear positive while 82 cases were culture positive. 
Among the 112 TB-HIV cases, 106 cases were ZN 
smear positive, while 72 cases were culture positive 
(Table 3).
Table 3
 ZN smear and culture results and logistic regression output for TB and TB-HIV patients
Variable TB patients TB-HIV patients OR 95%CI P-value
 N = 152 N = 112  
 +ve -ve +ve -ve
ZN smear 140 (92.1%) 12 (7.9%) 106 (94.6%) 6 (5.4%) 1.5143 0.5505-4.1653 0.4215 
Culture 82 (53.9%) 70 (46.1%) 72 (64.3%) 40 (35.7%) 1.5366 0.9309-2.5362 0.0929
Sensitivity, specificity, predictive values and receiver-
operating characteristic (ROC) curve: The sensitivity 
and specificity of ZN smear microscopy were 
88.1% and 79.7%, respectively.  The positive and 
negative predictive values were 58% and 95.5%, 
respectively (Table 4).  The value of the area 
under the ROC curve was 0.839, meaning that 
a randomly selected TB suspect from culture 
positive cases would have a test value larger than 
that for a randomly chosen suspect from culture 
negative cases in 83.9% of the time 30.  The 95% 
confidence interval (95%CI) was 0.80-0.87.  Since 
the P-value was low (P < 0.001), then the area 
under the ROC curve was significantly different 
from 0.5 (null hypothesis: Area = 0.5).  There was 
evidence that ZN smear microscopy had a lesser 
ability to distinguish between TB and non-TB 
cases compared to culture (Figure 1). 
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Figure 1 
ROC Test result ZN smear microscopy: 
Area under curve = 0.839; Standard error = 0.02; P < 0.001; 95CI, 0.80-0.87













Agreement and kappa statistic: Culture classified 
24.2% of all the 695 TB suspects tested for HIV 
as TB cases, and 75.5% of the suspects as non-TB 
cases.  If culture were to classify the TB suspects 
independent of classification by ZN smear 
microscopy, then 24.2% (61.71) of the 255 suspects 
classified as TB cases by ZN smear microscopy 
would be classified as TB cases.  Similarly, 24.2% 
(106.29) of the 440 suspects classified as non-
TB cases by ZN smear microscopy would be 
classified as non-TB cases by culture (Tables 4). 
Computations of percentage observed agreement 
and the percentage agreement expected by chance 
alone give 87.48% and 56.895%, respectively.  The 
value of kappa (k) in this case comes to 0.71 (Table 
4).  Since the k value lies between 0.40 and 0.75 
31, the two TB diagnostic tests are intermediate 
to good in agreement.
Table 4
Sensitivity, specificity and negative and positive predictive values, percentage 
observed agreement, percentage agreement expected by chance alone, and k value
              Culture 
 N = 695 positive      negative               Total
ZN smear 148      107               255(36.7%)
 20      420               440(63.3%)
 168 (24.2%)      527 (75.8%)               695(100%)
% sensitivity = 88.1; % specificity = 79.7; % NPV = 95.5; % PPV = 58.0
Percentage observed agreement = 87.48%
Percentage agreement expected by chance alone = 56.895%
Kappa (k) = 0.71.
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Antiretroviral therapy: During the period of the present 
study, 16.9% (46/272) of the HIV cases (14 TB-HIV and 
2 NTM-HIV) were put on antiretroviral therapy (ART), 
65.2% females and 34.8% males, respectively.  
DISCUSSION
Many previous studies have reported HIV infection to 
lower the rates of ZN smear microscopy sensitivity (7) 
and M. tuberculosis culture positivity (32), with smear 
positivity rates among TB cases as low as 31% (33, 
34).  Studies in India even reported smear negativity 
rates as high as 82% (6).  The sputum smear negativity 
tends to be associated with advanced HIV disease and 
progression in immuno-suppression (6). In the present 
study, HIV co-infection did not significantly affect 
ZN smear [P = 0.42] and culture [0.09], which differs 
from previous studies (7).  Plausible explanation for 
the apparent non-influence of HIV co-infection on 
ZN smear and culture sensitivity is that most the 
HIV positive TB cases may have been in the early 
HIV infection stage during which the frequency 
and presentation of TB is similar to that observed in 
immuno-competent and HIV negative cases (5,6). 
This explanation may be further supported by the 
fact that only 16.9% (46/272) of the cases were on 
anti-retroviral therapy (ART).  However, the present 
study did not establish HIV cases needing ART, 
as neither the CD4 cell count nor viral loads were 
determined.  The current study also did not examine 
the correlation between the clinical presentation of 
individual patients and the ZN smear microscopy 
and culture outcomes.  Nationally, however, of the 
1.4 million Kenyans infected with HIV, about 42.6% 
(243,000/570,000) of those needing ART were on 
therapy (35).  This means that Universal Access to 
ART in Kenya still remains a big challenge. 
 Moreover, from a significant proportion of the 
microscopically smear positive sputa, no mycobacteria 
could be cultured on Lowenstein-Jensen medium, nor 
on the more sensitive liquid MGIT media.  Only in 51% 
of the TB cases diagnosed by ZN smear microscopy 
could M. tuberculosis be grown from sputum. This 
implies that ZN microscopy as a diagnostic tool for 
TB among HIV/AIDS cases has become imprecise. 
However, the high number of ZN smear positive but 
culture negative cases observed in the present study 
may also be attributed either loss of viability since 
most sputum samples were cultured on the 7th day 
after collection, or the presence of fastidious NTM, or 
the presence of acid-fast non-mycobacteria organisms. 
Not all acid fast bacilli represent the M. tuberculosis 
complex.  Non-tuberculous mycobacteria (39) and 
some other bacterial species including Nocardia 
species which are widespread (40) yield positive 
results in ZN smear detection of acid-fast bacilli 
(AFB).  Similarly, a significant proportion of patients 
especially those HIV positive may give negative ZN 
smear results, although they are culture positive (41). 
It is therefore evident that TB diagnosis and treatment 
in Western Kenya is not completely evidence-based, 
and cases of non-tuberculous mycobacterioses are 
often put on anti-TB chemotherapy. Cases of non-
tuberculous mycobacterioses are often put on anti-TB 
chemotherapy, even though the treatment of NTM 
disease is generally not directly analogous to TB 
treatment.  Multi-drug regimes are used for NTM TB-
like disease treatment, the cornerstone agents being a 
newer macrolide (azithromycin, clarithromycin) (42), 
ethambutol, and rifamycin, and require prolonged 
durations of therapy aimed at facilitating clearance 
of the mycobacteria and minimising the emergence 
of drug resistance (41,42).  Consequently, yet to be 
found out is which ZN smear positive microorganisms 
cause this high degree of false-positivity and whether 
they are emerging infections.
 Previous studies have also indicated that positive 
blood cultures for TB (uncommon in HIV negative 
TB patients) may be a reflection of disseminated 
TB in patients with advanced HIV/AIDS.  Due to 
alteration of the normal host immune response to M. 
tuberculosis in HIV co-infected patients, cavitation and 
transfer of tubercle bacilli into respiratory secretions is 
markedly reduced, thereby hampering TB diagnosis 
by microscopy and culture (8,32).  The positivity of TB 
culture also varies with the nature of the specimen, 
ranging from 26 to 42% (36).  However, due to practical 
reasons the ZN smear microscopy so far remains the 
most feasible microbiological method for the diagnosis 
of PTB in developing countries due to its rapidity, low 
cost, and high positive predictive value for tubercle 
bacilli (37). Cultures are not performed for routine 
diagnosis and monitoring of TB treatment due to 
high costs and biosafety infrastructure requirements 
(37).  However, Dowdy et al. (38) reported that the TB 
culture is a potentially sensitive and cost-effective tool 
for HIV positive TB patients in resource-constrained 
settings, but integration with existing clinical systems 
and strengthening of post-analytical processes are 
required to maximise their impact.
  With the high prevalence of HIV/AIDS in the 
developing countries, there is the possibility that 
a substantial number of TB patients will be smear-
negative; or some HIV/AIDS patients may be smear-
positive due to NTM and acid-fast non-mycobacteria 
organisms.  Considering the relatively low sensitivity 
of ZN smear microscopy it is possible that a substantial 
number of HIV co-infected TB patients may already 
be missed to be initiated on treatment, a worrying 
situation since untreated TB from also smear negatives 
contributes to ongoing transmission (43). The 
increased prevalence of extra-pulmonary forms of TB 
in HIV infected patients is a further challenge to the 
management of TB in resource-poor settings, where 
access to histopathology and advanced imaging tests 
are limited or unavailable (35).  As TB rates continue 
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to increase in HIV endemic regions, there is merit 
for evaluation of the performance of diagnostic 
techniques as one of the TB control strategies.  There 
also remains a need to develop more user friendly 
TB diagnostic techniques, which can be efficiently 
adapted to use in the high-burden and low-income 
countries (1). There is also a need for large studies to 
identify selected clinical and laboratory parameters 
which could be used to identify TB in HIV positive 
individuals more accurately (31).
 Tremendous progress has been made in the 
diagnosis of TB in developed countries including 
replacing cultures with new molecular methods 
for TB diagnosis and drug susceptibility testing 
(DST).  However, TB diagnosis and DST methods 
have remained relatively unchanged (ZN smear 
microscopy and DST using LJ slants) in resource-
poor settings. The level of sophistication and cost 
associated with the new and more sensitive techniques 
have made their general applicability unfeasible in 
developing countries (44), where the basis for TB 
diagnosis has continued to be ZN smear microscopy 
to visualise acid-fast bacilli (AFB), which may capture 
50-60% of the cases when done by experienced 
personnel. However, in most low-income countries, 
much lower rates of case detection are achieved due 
to poor quality microscopes, heavy workload and 
shortage of appropriately trained technical staff. The 
latter could have also contributed to low accuracy of 
ZN smear microscopy due to moderate experience 
of most of the technical staff involved in the current 
study. Moreover, ZN smear microscopy is usually 
negative in advanced disease among HIV/AIDS 
co-infected patients and extra-pulmonary TB cases. 
The proportion of cases detected by microscopy in 
low-income countries is often as low as 20-30% of all 
cases (44, 45).  
 In the developed world, molecular detection 
and speciation of mycobacteria are currently the 
corner stone of the laboratory diagnosis of TB and 
NTM disease. Commercial DNA probes (AMPLICOR 
nucleic acid amplification test – Accuprobe) and the 
Gene – Probe Amplified Mycobacterium tuberculosis 
Direct Test (MTD) have been available in the developed 
world for sometime.  These tests are based on species-
specific DNA probes that hybridise with ribosomal 
RNA (rRNA) released from the mycobacteria (44). 
The other methods (INNO-LiPA Mycobacteria and the 
Hain’s GenoType Mycobacterium CM/AS) are based 
on reverse hybridisation, in which the mycobacteria 
16S-23S internal transcribed spacer region or the 
23S gene region are amplified by polymerase chain 
reaction (PCR), and the amplicons are subsequently 
hybridized with probes for several mycobacterial 
species on membrane strips (44). 
 This study had a limitation. The number of 
HIV cases needing ART could not be established. 
This is because the clinical characteristics (HIV 
immunosuppression phase/ CD4 cell counts, duration 
of disease, chest radiological features) that could also 
interfere with ZN smear and culture positivity rates 
were not determined.
In conclusion, the ZN microscopy as a diagnostic tool 
for TB appears to be imprecise and causes a significant 
over-diagnosis of TB among HIV/AIDS patients 
in western Kenya where there is high prevlence of 
HIV. There is need for further studies in this subject 
taking into consideration the various confounding 
factors. It is also unclear which micro-organisms 
other than mycobacteria cause positivity in ZN smear 
microscopy especially among HIV/AIDS patients 
and this needs to be examined further.
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